Back to HCC home

Text size

Large / Normal

Contact info

Diabetes & Metabolic Clinical Trials New Britain General campus
(860) 224-5616

Other info

Current Diabetes research trials

Indication: Type 2 diabetes

Sponsored by GlaxoSmithKline


A randomized, double-blind, placebo-controlled, parallel-group, multi-center study to determine the efficacy & safety of Albiglutide in Subjects with Type 2 diabetes. Albiglutide is a novel DPP-4 resistant GLP-1 once a week injection. It increases insulin secretion, decrease glucagon secretion and reduces appetite.

Inclusion Criteria:
  • 18 years or older
  • Diagnosed with Type 2 diabetes
  • Having trouble controlling your blood sugar level

Indication: Type 1 & 2 diabetes

Sponsored by GENOMAS


Establishment of a clinical registry & DNA repository for personalized management of diabetes mellitus. Observational study. A single blood sample is obtained for each patient. DNA will be analyzed to identify genetic markers that are predictive of treatment response to glitazones that effect glucose and lipids.

Inclusion Criteria:
  • Currently taking Avandia or Actos

Millions of people struggle to manage their Type 2 Diabetes.
Are you one of them?

Sponsored by Eli Lilly


Type 2 diabetes affects the quality of life for millions of adults. While sometimes diabetes can be controlled by exercise and diet, there are times when medication may be required. If you’ve been diagnosed with Type 2 Diabetes, consider taking part in a research study of an investigational medication for Type 2 Diabetes. Call (860) 224-5616 or visit for more information.

Inclusion Criteria

  • Diagnosed with Type 2 Diabetes